Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOREPEN LABS Plunges 3%; BSE HEALTHCARE Index Up 0.4%
Thu, 8 Aug 9:40

MOREPEN LABS Plunges 3%; BSE HEALTHCARE Index Up 0.4%Image source: Kameleon007 /www.istockphoto.com

MOREPEN LABS share price has plunged 3% and is presently trading at Rs 58.7.

Meanwhile, the BSE HEALTHCARE index is at 41,010.6 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are GRANULES INDIA (down 2.2%) and DR. LAL PATHLABS (down 2.1%).

ALEMBIC PHARMA (up 3.1%) and ERIS LIFESCIENCES (up 2.6%) are among the top gainers today.

Over the last one year, MOREPEN LABS has moved up from Rs 33.1 to Rs 58.7, registering a gain of Rs 25.6 (up 77.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,010.6, registering a gain of 44.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 117.0%), GSK Pharma (up 105.8%) and SUVEN PHARMACEUTICALS (up 104.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,281.5 (down 0.2%).

The top losers among the BSE Sensex today are Infosys (down 1.6%) and JSW Steel (down 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,221.7 (down 0.3%). JSW Steel and Infosys are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,281.5, registering a gain of 13,328.0 points (up 20.2%).

MOREPEN LABS Financial Update...

MOREPEN LABS net profit grew 248.7% YoY to Rs 287 million for the quarter ended March 2024, compared to a profit of Rs 82 million a year ago. Net sales rose 16.3% to Rs 4,231 million during the period as against Rs 3,637 million in January-March 2023.

For the year ended March 2023, MOREPEN LABS reported 62.0% decrease in net profit to Rs 387 million compared to net profit of Rs 1,017 million during FY22. Revenue of the company fell 8.4% to Rs 14,175 million during FY23.

The current Price to earnings ratio of MOREPEN LABS, based on rolling 12 month earnings, stands at 33.3.


Equitymaster requests your view! Post a comment on "MOREPEN LABS Plunges 3%; BSE HEALTHCARE Index Up 0.4%". Click here!